SAFETY MONITORING GUIDELINES FOR TREATMENTS FOR MAJOR DEPRESSIVE DISORDER

被引：0

作者：

Dodd, S. ^{[1
,2
]}

Malhi, G. S.

Tiller, J. ^{[4
]}

Schweitzer, I. ^{[4
]}

Hickie, I. ^{[3
]}

Khoo, J. P. ^{[5
]}

Basset, D. L. ^{[6
]}

Lyndon, B.

Mitchell, P. B. ^{[7
]}

Parker, G. ^{[7
]}

Fitzgerald, P. B. ^{[8
]}

Udina, M. ^{[9
]}

Singh, A. ^{[2
]}

Moylan, S. ^{[1
]}

Giorlando, F. ^{[2
]}

Doughty, C. ^{[10
]}

Davey, C. G. ^{[11
]}

Theodoros, M. ^{[12
]}

Berk, M. ^{[1
,2
,11
]}

机构：

[1] Deakin Univ, Geelong, Vic 3217, Australia

[2] Univ Melbourne, Geelong, Vic, Australia

[3] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia

[4] Univ Melbourne, Melbourne, Vic, Australia

[5] Toowong Specialist Clin, Brisbane, Qld, Australia

[6] Univ Western Australia, Perth, WA 6009, Australia

[7] Univ New S Wales, Sydney, NSW, Australia

[8] Monash Univ, Melbourne, Vic 3004, Australia

[9] Univ Barcelona, Barcelona, Spain

[10] Univ Otago, Christchurch, New Zealand

[11] Orygen Youth Hlth Res Ctr, Melbourne, Vic, Australia

[12] New Farm Clin, Brisbane, Qld, Australia

来源：

EUROPEAN PSYCHIATRY | 2012年 / 27卷

关键词：

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

O-10

引用

页数：1

共 50 条

[31] Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder [J].

Zhang, Xiao-Fei ;

Wu, Lei ;

Wan, Dong-Jun ;

Liu, Ruo-Zhuo ;

Dong, Zhao ;

Chen, Min ;

Yu, Sheng-Yuan .

NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 :1957-1965

[32] Safety of quetiapine for treatment of insomnia in patients with major depressive disorder [J].

Lee, S. ;

Han, J. H. ;

Hong, S. C. ;

Jeong, J. H. ;

Seo, H. J. ;

Lim, H. K. .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 :S377-S378

[33] Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Safety and Tolerability [J].

Papakostas, George ;

Fava, Maurizio ;

Mischoulon, David ;

Shelton, Richard .

NEUROPSYCHOPHARMACOLOGY, 2015, 40 :S146-S147

[34] Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments [J].

Parikh, Sagar V. ;

Quilty, Lena C. ;

Ravitz, Paula ;

Rosenbluth, Michael ;

Pavlova, Barbara ;

Grigoriadis, Sophie ;

Velyvis, Vytas ;

Kennedy, Sidney H. ;

Lam, Raymond W. ;

MacQueen, Glenda M. ;

Milev, Roumen V. ;

Ravindran, Arun V. ;

Uher, Rudolf .

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2016, 61 (09) :524-539

[35] Safety and Tolerability of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder [J].

Findling, Robert L. ;

Groark, James ;

Chiles, Deborah ;

Ramaker, Sara ;

Yang, Lingfeng ;

Tourian, Karen A. .

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (04) :201-209

[36] Efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder [J].

Kamath, Jayesh ;

DeMartinis, Nicholas ;

Handratta, Venkatesh .

FUTURE NEUROLOGY, 2007, 2 (04) :361-371

[37] PLASMA PHOSPHOETHANOLAMINE LEVELS AS A BIOMARKER FOR MONITORING MAJOR DEPRESSIVE DISORDER [J].

Kawamura, Noriyuki ;

Nakata, Akinori ;

Harada, Tsuyoto ;

Ohashi, Yoshiaki ;

Sato, Hajime ;

Sasaki, Kazunori ;

Higuchi, Teruhiko .

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 :i33-i34

[38] Dysfunctional thinking in major depressive disorder: A deficit in metacognitive monitoring? [J].

Sheppard, LC ;

Teasdale, JD .

JOURNAL OF ABNORMAL PSYCHOLOGY, 2000, 109 (04) :768-776

[39] Monitoring of liver function in major depressive disorder treated with SSRI [J].

Ifteni, P. ;

Teodorescu, A. .

EUROPEAN PSYCHIATRY, 2016, 33 :S158-S158

[40] Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Introduction and Methods [J].

Lam, Raymond W. ;

Kennedy, Sidney H. ;

Parikh, Sagar V. ;

MacQueen, Glenda M. ;

Milev, Roumen V. ;

Ravindran, Arun V. .

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2016, 61 (09) :506-509

← 1 2 3 4 5 →